Clinical - ABL SA : ABL SA

EMRs - Registries - Integration tool

Read more

Nadis EMR

Read more

Clinical solutions

Discover our solutions

Clinical applications

Discover our applications

ABL Announces Distribution Agreement with ROCHEM BIOCARE in Panama

Apr 12, 2018

Advanced Biological Laboratories (ABL) S.A. and ROCHEM BIOCARE DE PANAMA, S.A. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Panama. See current channel partners.
Read more
ABL Announces Distribution Agreement with Laborama Ltd. in Lithuania

Apr 05, 2018

Advanced Biological Laboratories (ABL) S.A. and Laborama Ltd. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Lithuania. See current channel partners.
Read more
Immediate Availability of New DeepChek Assays for Cytomegalovirus (CMV) and Mycobacterium tuberculosis (TB) Drug Resistance

Mar 27, 2018

ABL is pleased to announce the immediate available of two new DeepChek® Assays intended to be used for: Determining antiviral drug resistance to cidofovir, foscarnet sodium, ganciclovir and maribavir in patients infected with cytomegalovirus (CMV) – DEEPCHEK®-CMV UL54/UL97 ASSAY Determining dr…
Read more

ABL and Thermo Fisher Scientific Corporation Ink Supply Agreement on Capillary Electrophoresis Instruments

Jan 22, 2018

ABL and Thermo Fisher Scientific Corporation are pleased to announce the execution of a supply agreement conferring to ABL the ability to combine Thermo Fisher Scientific Corporation’s Genetic Analyzers (3500 Genetic Analyzer, Applied Biosystem SeqStudio Genetic Analyzer…) with its DeepC…
Read more
ABL-EVIVAR Obtains New Patent Allowance on Hepatitis B Virus Polymerase Gene

Dec 19, 2017

ABL is pleased to announce the allowance of a new patent covering new Hepatitis B primers and kits hybridizing to DNA or mRNA of the Hepatitis B Virus Polymerase gene.
Read more
DeepChek®-HIV RT/PROT and DeepChek®-HIV INT Genotyping Assays Successfully Passed 2016 National Quality Control Program with 100% Accuracy.

Sep 19, 2017

We are pleased to announce that the DeepChek®-HIV RT/PROT assay and the DeepChek®-HIV INT assay successfully passed a national and independent quality control program in France and Switzerland and obtained 100% positive results on sensibility, 100% on specificity and also 100% on scoring on HIV geno…
Read more

Highlights on innovative molecular biology assays designed for detection, quantification and genotyping applications in virology

Sep 08, 2017

Together with our partner in Italy, Technogenetics, we are delighted to have two international experts in the field of molecular virology share their experience in clinical microbiology and laboratory management using our solutions (reagents and software) at the Technogenetics Satellite Symposium or…
Read more
ABL Announces Distribution Agreement with ABALAT in Mexico

Sep 04, 2017

Advanced Biological Laboratories (ABL) S.A. and ABALAT S.A. are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Mexico. See current channel partners.
Read more
Information Note – September 2017

Sep 01, 2017

We are pleased to share with you recent updates on ABL Diagnostics solutions: DeepChek Software v3.27 released including: Largescale mode: launch analyses on multiple samples simultaneously New One-page Report New version of HIVDB drug resistance guidelines (v8.4) HCV reference subtypes updated acco…
Read more